Market Cap (In JPY)
6.54 Billion
Revenue (In JPY)
1 Billion
Net Income (In JPY)
260.33 Million
Avg. Volume
202.86 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 550.0-1016.0
- PE
- -8.57
- EPS
- -65.8
- Beta Value
- 0.0
- ISIN
- JP3280900006
- CUSIP
- -
- CIK
- -
- Shares
- 11604600.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Hiroaki Fukushima
- Employee Count
- -
- Website
- https://www.kpharma.co.jp
- Ipo Date
- 2023-10-17
- Details
- K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan.
More Stocks
-
R
-
NAGPI
-
AVCNFAvicanna Inc.
AVCNF
-
NMAN
-
SMTEFSmart Eye AB (publ)
SMTEF
-
INHINDUS Holding AG
INH
-
HERCULESHercules Hoists Limited
HERCULES
-
DFDSDFDS A/S
DFDS